MNKA — Manuka Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- $0.59m
- $0.31m
Annual income statement for Manuka, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0.311 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 0.257 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 0.772 | 0.168 | 0.167 | 0.154 | 1.67 |
| Operating Profit | -0.772 | -0.168 | -0.167 | -0.154 | -1.36 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.513 | -0.174 | -0.174 | -0.167 | -1.35 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.513 | -0.121 | -0.121 | -0.167 | -1.35 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.513 | -0.121 | -0.121 | -0.167 | -1.35 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.436 | -0.103 | -0.103 | -0.142 | -1.35 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.085 | -0.02 | -0.02 | -0.028 | -0.024 |